PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsApellis Pharmaceuticals
Apellis Pharmaceuticals(APLS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
EmpaveliPegcetacoplan2021-05-142026-2038
Paroxysmal hemoglobinuria
SyfovrePegcetacoplan2023-02-172026-2038
Paroxysmal hemoglobinuria
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Pegcetacoplan
ischemic stroke
,
cerebral infarction
,
reperfusion injury
,
thromboinflammation
,
wet macular degeneration
,
hemolytic anemia
,
amyotrophic lateral sclerosis
,
motor neuron disease
,
sclerosis
,
kidney diseases
,
iga glomerulonephritis
,
membranous glomerulonephritis
,
lupus nephritis
,
nephritis
,
anemia
,
hemolysis
,
ovarian neoplasms
,
endometrioid carcinoma
,
serous cystadenocarcinoma
,
fallopian tube neoplasms
,
carcinosarcoma
,
acinar cell carcinoma
,
pancreatic ductal carcinoma
,
pancreatic neoplasms
,
geographic atrophy
,
macular degeneration
,
paroxysmal hemoglobinuria
,
hemoglobinuria
,
atrophy
,
kidney transplantation
,
hemolytic anemia autoimmune
,
chronic kidney failure
,
delayed graft function
,
glomerulonephritis
,
membranoproliferative glomerulonephritis
,
rare diseases
Aspartame
tuberculosis
,
neoplasms
,
myeloid leukemia acute
,
deficiency diseases
,
paraproteinemias
,
hiv infections
,
precursor cell lymphoblastic leukemia-lymphoma
,
breast neoplasms
,
immune system diseases
,
hematologic neoplasms
,
type 2 diabetes mellitus
,
uveitis
,
metabolic diseases
,
disease
,
glycogen storage disease
,
lipidoses
,
immunoglobulin g4-related disease
,
leukemia
,
myeloid leukemia
,
malaria
,
falciparum malaria
,
whooping cough
,
tetanus
,
diphtheria
,
tetany
,
polycystic kidney diseases
,
autosomal dominant polycystic kidney
,
arthrogryposis
,
recurrence
,
renal insufficiency
,
hematologic diseases
,
blood protein disorders
,
neoplasms by histologic type
,
prostatic neoplasms
,
circulating neoplastic cells
,
x-linked bulbo-spinal atrophy
,
heart transplantation
,
non-small-cell lung carcinoma
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
esophageal neoplasms
,
adenocarcinoma
,
neoplasm metastasis
,
aplastic anemia
,
multiple myeloma
,
hypercholesterolemia
,
meningococcal infections
,
plasma cell neoplasms
,
hemolytic anemia autoimmune
,
meningitis
,
meningococcal meningitis
,
stomach neoplasms
,
hemophilia a
,
kidney diseases
,
gaucher disease
,
hemophilia b
,
chronic renal insufficiency
,
hyperphosphatemia
,
multiple sclerosis
,
sclerosis
,
homozygous familial hypercholesterolemia
,
hyperlipoproteinemia type ii
,
pharyngitis
,
tonsillitis
,
healthy volunteers/patients
,
asthma
,
glycogen storage disease type ii
,
atopic dermatitis
,
diabetes mellitus
,
insulin resistance
,
hyperglycemia
,
glycogen storage disease type iii
,
heartburn
,
non-hodgkin lymphoma
,
osteoporosis
,
postmenopausal osteoporosis
,
lymphoma
,
lymphoproliferative disorders
Nepidermin
breast neoplasms
,
carcinoma
,
head and neck neoplasms
,
squamous cell carcinoma of head and neck
,
non-small-cell lung carcinoma
,
neoplasm metastasis
,
myofascial pain syndromes
,
fibromyalgia
,
syndrome
,
hemangioma
,
port-wine stain
,
capillary hemangioma
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
melanoma
,
myelodysplastic syndromes
,
myeloid leukemia acute
,
healthy volunteers/patients
Decellularized dermal allograft
leukemia
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
lymphoproliferative disorders
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use